lobbying_activities: 1223772
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1223772 | 5ee68a3d-8217-4ef3-a6db-8e1a5fce5bea | Q1 | CSL BEHRING LLC | 308935 | CSL BEHRING LLC | 2012 | first_quarter | TAX | Implementation and revision of the orphan drug exception from the annual branded pharmaceutical fee which was enacted in the Affordable Care Act | HOUSE OF REPRESENTATIVES,SENATE | 110000 | 0 | 0 | 2012-04-05T14:34:47.330000-04:00 |